Tirzepatide in Idiopathic Intracranial Hypertension Trial
Tirzepatide in Idiopathic Intracranial Hypertension Trial
Recruiting · NCT07191873 · Registry updated 2026-09-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tirzepatide in Idiopathic Intracranial Hypertension Trial | Headache, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, brain disorder, central nervous system disorder, intracranial hypertension, nervous system disorder, pseudotumor cerebri | Recruiting | Phase 4 | 2026-09-15 | NCT07191873 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Duke University | 446 |
| Eli Lilly and Company | 370 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Duke University Medical Center | Durham | United States | 505 |